Procaps Group S.A. Warrants
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more
Procaps Group S.A. Warrants (PROCW) - Total Assets
Latest total assets as of September 2023: $498.55 Million USD
Based on the latest financial reports, Procaps Group S.A. Warrants (PROCW) holds total assets worth $498.55 Million USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Procaps Group S.A. Warrants - Total Assets Trend (2019–2022)
This chart illustrates how Procaps Group S.A. Warrants’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Procaps Group S.A. Warrants - Asset Composition Analysis
Current Asset Composition (December 2022)
Procaps Group S.A. Warrants's total assets of $498.55 Million consist of 64.6% current assets and 35.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.3% |
| Accounts Receivable | $153.26 Million | 33.3% |
| Inventory | $96.83 Million | 21.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $32.21 Million | 7.0% |
| Goodwill | $5.79 Million | 1.3% |
Asset Composition Trend (2019–2022)
This chart illustrates how Procaps Group S.A. Warrants's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Procaps Group S.A. Warrants's current assets represent 64.6% of total assets in 2022, an increase from 51.1% in 2019.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2022, up from 0.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 33.3% of total assets.
Procaps Group S.A. Warrants Competitors by Total Assets
Key competitors of Procaps Group S.A. Warrants based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Procaps Group S.A. Warrants - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Procaps Group S.A. Warrants generates 0.89x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Procaps Group S.A. Warrants generates $9.24 in net profit.
Procaps Group S.A. Warrants - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 1.38 | 0.69 |
| Quick Ratio | 0.99 | 0.93 | 0.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $95.42 Million | $ 83.91 Million | $ -19.01 Million |
Procaps Group S.A. Warrants - Advanced Valuation Insights
This section examines the relationship between Procaps Group S.A. Warrants's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.4% |
| Total Assets | $460.19 Million |
| Market Capitalization | $332.72K USD |
Valuation Analysis
Below Book Valuation: The market values Procaps Group S.A. Warrants's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Procaps Group S.A. Warrants's assets decreased by 0.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Procaps Group S.A. Warrants (2019–2022)
The table below shows the annual total assets of Procaps Group S.A. Warrants from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $460.19 Million | -0.42% |
| 2021-12-31 | $462.13 Million | +28.54% |
| 2020-12-31 | $359.54 Million | +6.46% |
| 2019-12-31 | $337.73 Million | -- |